Back to 
Susquehanna International Group, LLP
Susquehanna International Group, LLP
ARCT
Showing 0 of 2 quarters
Position history for Susquehanna International Group, LLP's holdings in Arcturus Therapeutics Holdings Inc.
No. Susquehanna International Group exited its ARCT (Arcturus Therapeutics Holdings) position in Q1 2019. Its Q4 2018 13F listed 39,351 shares worth $178,000. Susquehanna International Group already held ARCT in its Q4 2018 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.